1. Home
  2. CBL vs AXGN Comparison

CBL vs AXGN Comparison

Compare CBL & AXGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CBL
  • AXGN
  • Stock Information
  • Founded
  • CBL 1978
  • AXGN N/A
  • Country
  • CBL United States
  • AXGN United States
  • Employees
  • CBL N/A
  • AXGN N/A
  • Industry
  • CBL Real Estate Investment Trusts
  • AXGN Biotechnology: Electromedical & Electrotherapeutic Apparatus
  • Sector
  • CBL Real Estate
  • AXGN Health Care
  • Exchange
  • CBL Nasdaq
  • AXGN Nasdaq
  • Market Cap
  • CBL 777.7M
  • AXGN 789.6M
  • IPO Year
  • CBL 1993
  • AXGN N/A
  • Fundamental
  • Price
  • CBL $29.23
  • AXGN $16.86
  • Analyst Decision
  • CBL
  • AXGN Strong Buy
  • Analyst Count
  • CBL 0
  • AXGN 6
  • Target Price
  • CBL N/A
  • AXGN $25.83
  • AVG Volume (30 Days)
  • CBL 116.7K
  • AXGN 914.5K
  • Earning Date
  • CBL 11-10-2025
  • AXGN 11-06-2025
  • Dividend Yield
  • CBL 6.16%
  • AXGN N/A
  • EPS Growth
  • CBL 128.05
  • AXGN N/A
  • EPS
  • CBL 2.10
  • AXGN N/A
  • Revenue
  • CBL $539,452,000.00
  • AXGN $203,271,000.00
  • Revenue This Year
  • CBL N/A
  • AXGN $19.65
  • Revenue Next Year
  • CBL N/A
  • AXGN $15.84
  • P/E Ratio
  • CBL $13.86
  • AXGN N/A
  • Revenue Growth
  • CBL 2.20
  • AXGN 17.17
  • 52 Week Low
  • CBL $21.10
  • AXGN $9.22
  • 52 Week High
  • CBL $33.54
  • AXGN $21.00
  • Technical
  • Relative Strength Index (RSI)
  • CBL 39.34
  • AXGN 51.72
  • Support Level
  • CBL $29.80
  • AXGN $17.01
  • Resistance Level
  • CBL $30.70
  • AXGN $18.64
  • Average True Range (ATR)
  • CBL 0.64
  • AXGN 0.69
  • MACD
  • CBL -0.22
  • AXGN -0.12
  • Stochastic Oscillator
  • CBL 6.46
  • AXGN 9.93

About CBL CBL & Associates Properties Inc.

CBL & Associates Properties Inc is a real estate investment trust. The company engages in the ownership, development, acquisition, leasing, management and operation of regional shopping malls, outlet centers, lifestyle centers, open-air centers and other properties. CBL's sales predominantly derive from leasing arrangements with retail tenants. The company also generates revenue from management and development fees, as well as sales of its real estate assets. CBL expands its portfolio of assets through activities such as redevelopment, renovation, and expansion.

About AXGN Axogen Inc.

Axogen Inc is engaged in the science, development, and commercialization of technologies for peripheral nerve regeneration and repair. The company provides clinically, economically effective repair solutions for surgeons and health care providers. Its products include Avance Nerve Graft, Axoguard Nerve Connector, Axoguard Nerve Protector, Axoguard Nerve Cap and Avive Soft Tissue Membrane. It also offers an Axotouch Two-Point Discriminator used to measure the innervation density of any surface area of the skin. Its products are available in the United States, Canada, Germany, the United Kingdom, Spain, South Korea, and several other countries.

Share on Social Networks: